Physician profile
Michael S Wang
NPI 1912913302
$620.52
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $12.55 · 2021: $85.30 · 2022: $269 · 2023: $23.32 · 2024: $22.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $45.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $45.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $184.99 | 2022 | |
| Boston Scientific Corporation | $130.84 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $109.49 | 2019 | |
| Insmed, INC. | $99.00 | 2019 | |
| Teleflex LLC | $63.22 | 2022 | |
| Endo Pharmaceuticals INC. | $20.43 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.55 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.